These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11975851)

  • 1. Adenovirally transduced dendritic cells induce bispecific cytotoxic T lymphocyte responses against adenovirus and cytomegalovirus pp65 or against adenovirus and Epstein-Barr virus EBNA3C protein: a novel approach for immunotherapy.
    Hamel Y; Blake N; Gabrielsson S; Haigh T; Jooss K; Martinache C; Caillat-Zucman S; Rickinson AB; Hacein-Bey S; Fischer A; Cavazzana-Calvo M
    Hum Gene Ther; 2002 May; 13(7):855-66. PubMed ID: 11975851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein-Barr virus: an approach for adoptive immunotherapy of multiple pathogens.
    Karlsson H; Brewin J; Kinnon C; Veys P; Amrolia PJ
    J Immunother; 2007; 30(5):544-56. PubMed ID: 17589295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells.
    Keever-Taylor CA; Margolis D; Konings S; Sandford GR; Nicolette CA; Lawendowski C; Burns WH
    Biol Blood Marrow Transplant; 2001; 7(5):247-56. PubMed ID: 11400946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants.
    Lucas KG; Sun Q; Burton RL; Tilden A; Vaughan WP; Carabasi M; Salzman D; Ship A
    Hum Gene Ther; 2000 Jul; 11(10):1453-63. PubMed ID: 10910142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation.
    Hanley PJ; Shaffer DR; Cruz CR; Ku S; Tzou B; Liu H; Demmler-Harrison G; Heslop HE; Rooney CM; Gottschalk S; Bollard CM
    Cytotherapy; 2011 Sep; 13(8):976-86. PubMed ID: 21539497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells.
    Forsberg O; Carlsson B; Tötterman TH; Essand M
    Br J Haematol; 2008 Apr; 141(2):188-99. PubMed ID: 18307565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of T-cell immunity against Epstein-Barr virus-associated tumors by means of adenovirally transduced dendritic cells.
    Sun H; Yao K; Chen Y; Zhou F
    Chin Med J (Engl); 2004 Oct; 117(10):1558-63. PubMed ID: 15498383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous ex vivo expansion of cytomegalovirus and Epstein-Barr virus-specific cytotoxic T lymphocytes using B-lymphoblastoid cell lines expressing cytomegalovirus pp65.
    Sun Q; Pollok KE; Burton RL; Dai LJ; Britt W; Emanuel DJ; Lucas KG
    Blood; 1999 Nov; 94(9):3242-50. PubMed ID: 10556213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies.
    Gottschalk S; Edwards OL; Sili U; Huls MH; Goltsova T; Davis AR; Heslop HE; Rooney CM
    Blood; 2003 Mar; 101(5):1905-12. PubMed ID: 12411306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses.
    Heine A; Grünebach F; Holderried T; Appel S; Weck MM; Dörfel D; Sinzger C; Brossart P
    Mol Ther; 2006 Feb; 13(2):280-8. PubMed ID: 16219490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo stimulation of cytomegalovirus (CMV)-specific T cells using CMV pp65-modified dendritic cells as stimulators.
    Carlsson B; Cheng WS; Tötterman TH; Essand M
    Br J Haematol; 2003 May; 121(3):428-38. PubMed ID: 12716365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of three HLA-A*0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus.
    Solache A; Morgan CL; Dodi AI; Morte C; Scott I; Baboonian C; Zal B; Goldman J; Grundy JE; Madrigal JA
    J Immunol; 1999 Nov; 163(10):5512-8. PubMed ID: 10553078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous generation of cytomegalovirus-specific CD8+ and CD4+ T lymphocytes by use of dendritic cells comodified with pp65 mRNA and pp65 protein.
    Carlsson B; Hou M; Giandomenico V; Nilsson B; Totterman TH; Essand M
    J Infect Dis; 2005 Dec; 192(11):1912-20. PubMed ID: 16267762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous generation of multivirus-specific and regulatory T cells for adoptive immunotherapy.
    Lugthart G; Albon SJ; Ricciardelli I; Kester MG; Meij P; Lankester AC; Amrolia PJ
    J Immunother; 2012 Jan; 35(1):42-53. PubMed ID: 22130159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus--positive Hodgkin's lymphoma.
    Gahn B; Siller-Lopez F; Pirooz AD; Yvon E; Gottschalk S; Longnecker R; Brenner MK; Heslop HE; Aguilar-Cordova E; Rooney CM
    Int J Cancer; 2001 Sep; 93(5):706-13. PubMed ID: 11477583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccination.
    Ranieri E; Herr W; Gambotto A; Olson W; Rowe D; Robbins PD; Kierstead LS; Watkins SC; Gesualdo L; Storkus WJ
    J Virol; 1999 Dec; 73(12):10416-25. PubMed ID: 10559360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CMV pp65 gene modified dendritic cells activate autologous T cells].
    Gao GX; Chen XQ; Zhang JY; Zhu HF; Dong BX; Gu HT; Gao Y; Pan YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):397-400. PubMed ID: 18426673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers.
    Szmania S; Galloway A; Bruorton M; Musk P; Aubert G; Arthur A; Pyle H; Hensel N; Ta N; Lamb L; Dodi T; Madrigal A; Barrett J; Henslee-Downey J; van Rhee F
    Blood; 2001 Aug; 98(3):505-12. PubMed ID: 11468143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells.
    Nair SK; De Leon G; Boczkowski D; Schmittling R; Xie W; Staats J; Liu R; Johnson LA; Weinhold K; Archer GE; Sampson JH; Mitchell DA
    Clin Cancer Res; 2014 May; 20(10):2684-94. PubMed ID: 24658154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of antigen-specific repertoire diversity following in vitro restimulation by a recombinant adenovirus expressing human cytomegalovirus pp65.
    Hamel Y; Rohrlich P; Baron V; Bonhomme D; Rieux-Laucat F; Necker A; Lemonnier F; Ferradini L; Fischer A; Cavazzana-Calvo M
    Eur J Immunol; 2003 Mar; 33(3):760-8. PubMed ID: 12616496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.